{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:13:44Z","timestamp":1793729624965,"version":"4.6.1"},"reference-count":169,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jaip.2023.05.011","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T22:49:40Z","timestamp":1684363780000},"page":"2630-2641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti\u2013IL-5 Biologic Therapy"],"prefix":"10.1016","volume":"11","author":[{"given":"Claus","family":"Bachert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber U.","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Mullol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria S.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhabita","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.05.011_bib1","first-page":"7","article-title":"The nose-lung interaction in allergic rhinitis and asthma: united airways disease","volume":"1","author":"Passalacqua","year":"2001","journal-title":"Curr Op Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.rmed.2016.06.012","article-title":"Profile of difficult to treat asthma patients referred for systematic assessment","volume":"117","author":"Radhakrishna","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fphar.2020.01147","article-title":"NSAID-exacerbated respiratory disease (NERD): from pathogenesis to improved care","volume":"11","author":"Woo","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2023.05.011_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/JAA.S81541","article-title":"United airway disease: current perspectives","volume":"9","author":"Giavina-Bianchi","year":"2016","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib5","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2020.02.018","article-title":"Assessing the unified airway hypothesis in children via transcriptional profiling of the airway epithelium","volume":"145","author":"Kicic","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2500\/ajra.2012.26.3762","article-title":"The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis","volume":"26","author":"Feng","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib6","first-page":"441","article-title":"Differences and similarities between the upper and lower airway: focusing on innate immunity","volume":"59","author":"Cho","year":"2021","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2023.05.011_bib17","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision","volume":"126","author":"Brozek","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.011_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100464","article-title":"Oral corticoSteroid sparing with biologics in severe asthma: a remark of the Severe Asthma Network in Italy (SANI)","volume":"13","author":"Canonica","year":"2020","journal-title":"World Allergy Org J"},{"key":"10.1016\/j.jaip.2023.05.011_bib19","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/all.13875","article-title":"EUFOREA consensus on biologics for CRSwNP with or without asthma","volume":"74","author":"Fokkens","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib20","first-page":"45","article-title":"Nasal polyps in patients with asthma: prevalence, impact, and management challenges","volume":"9","author":"Langdon","year":"2016","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)\u2014a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib22","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00405-016-4366-x","article-title":"Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study","volume":"274","author":"Gudziol","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2023.05.011_bib23","first-page":"37","article-title":"Smell improvement by anti-IgE and anti-IL 5 biologics in patients with CRSwNP and severe asthma. A real life study","volume":"33","author":"Barroso","year":"2022","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/all.13373","article-title":"Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited","volume":"73","author":"Samitas","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2023.05.011_bib11","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jaip.2022.04.039","article-title":"Management of united airway disease focused on patients with asthma and chronic rhinosinusitis with nasal polyps: a systematic review","volume":"10","author":"Mullol","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.011_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12931-018-0823-y","article-title":"Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study","volume":"19","author":"Philpott","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2023.05.011_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2500\/ajra.2015.29.4123","article-title":"Factors driving the aspirin exacerbated respiratory disease phenotype","volume":"29","author":"Steinke","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of disease in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma\u2014present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib25","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.jaci.2017.08.012","article-title":"TNF-alpha-induced protein 3 levels in lung dendritic cells instruct TH2 or TH17 cell differentiation in eosinophilic or neutrophilic asthma","volume":"141","author":"Vroman","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaci.2016.10.034","article-title":"Identification of IL-17F\/frequent exacerbator endotype in asthma","volume":"140","author":"Ricciardolo","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12016-018-8712-1","article-title":"Understanding asthma phenotypes, endotypes, and mechanisms of disease","volume":"56","author":"Kuruvilla","year":"2019","journal-title":"Clinical Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib28","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.011_bib29","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.3390\/biomedicines10112911","article-title":"Neutrophils play an important role in the recurrence of chronic rhinosinusitis with nasal polyps","volume":"10","author":"Yu","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaip.2023.05.011_bib30","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2020.11.001","article-title":"Inflammatory heterogeneity in aspirin-exacerbated respiratory disease","volume":"147","author":"Scott","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib31","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","article-title":"Eosinophils in health and disease: a state-of-the-art review","volume":"96","author":"Wechsler","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2023.05.011_bib32","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/alr.22994","article-title":"The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polyps","volume":"12","author":"Gevaert","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib33","author":"Kia\u2019i"},{"key":"10.1016\/j.jaip.2023.05.011_bib34","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1152\/japplphysiol.00950.2012","article-title":"Airway smooth muscle in the pathophysiology and treatment of asthma","volume":"114","author":"Doeing","year":"2013","journal-title":"J\u00a0App Physiol"},{"key":"10.1016\/j.jaip.2023.05.011_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2152656718764233","article-title":"Autonomic nervous system dysfunction and sinonasal symptoms","volume":"9","author":"Yao","year":"2018","journal-title":"Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/alr.22780","article-title":"Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"11","author":"Hopkins","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib38","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","article-title":"IL-5- and eosinophil-mediated inflammation: from discovery to therapy","volume":"21","author":"Kouro","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib39","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1111\/all.14297","article-title":"Human airway epithelial cells express a functional IL-5 receptor","volume":"75","author":"Barretto","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2021.05.043","article-title":"Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease","volume":"148","author":"Buchheit","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib41","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jaci.2020.02.035","article-title":"IL-5Ralpha marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease","volume":"145","author":"Buchheit","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2222.2011.03854.x","article-title":"Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor","volume":"42","author":"Molfino","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib48","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI95693","article-title":"Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction","volume":"128","author":"Dunican","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.05.011_bib49","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1164\/rccm.202110-2265OC","article-title":"Mucus plugs persist in asthma, and changes in mucus plugs associate with changes in airflow over time","volume":"205","author":"Tang","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib50","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1164\/arrd.1987.135.4.848","article-title":"The effect of purified human eosinophil major basic protein on mammalian ciliary activity","volume":"135","author":"Hastie","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2023.05.011_bib51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jaci.2008.01.005","article-title":"Increased sputum and bronchial biopsy IL-13 expression in severe asthma","volume":"121","author":"Saha","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib43","first-page":"e85","article-title":"Airway remodelling in asthma: from benchside to clinical practice","volume":"17","author":"Bergeron","year":"2010","journal-title":"Can Respir J"},{"key":"10.1016\/j.jaip.2023.05.011_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2147\/JAA.S267222","article-title":"Pathobiology of airway remodeling in asthma: the emerging role of integrins","volume":"15","author":"Joseph","year":"2022","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib45","article-title":"Sinonasal tissue remodelling during chronic rhinosinusitis","volume":"2021","author":"Amirapu","year":"2021","journal-title":"Int J Otolaryngol"},{"key":"10.1016\/j.jaip.2023.05.011_bib46","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/ijms22020910","article-title":"Advances in the knowledge of the underlying airway remodeling mechanisms in chronic rhinosinusitis based on the endotypes: a review","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2023.05.011_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.alit.2019.05.001","article-title":"Aspirin-exacerbated respiratory disease (AERD): current understanding of AERD","volume":"68","author":"Taniguchi","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2023.05.011_bib52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0091-6749(86)90341-6","article-title":"The eosinophil and the pathophysiology of asthma","volume":"77","author":"Frigas","year":"1986","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib53","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1365-2222.1998.00331.x","article-title":"Induced sputum eosinophil cationic protein (ECP) measurement in asthma and chronic obstructive airway disease (COAD)","volume":"28","author":"Gibson","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib54","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4168\/aair.2019.11.3.394","article-title":"Serum levels of eosinophil-derived neurotoxin: a biomarker for asthma severity in adult asthmatics","volume":"11","author":"Lee","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2023.05.011_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2466-4-2","article-title":"Serum interleukin-5 levels are elevated in mild and moderate persistent asthma irrespective of regular inhaled glucocorticoid therapy","volume":"4","author":"Joseph","year":"2004","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib56","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","article-title":"Nasal IL-5 levels determine the response to anti\u2013IL-5 treatment in patients with nasal polyps","volume":"118","author":"Gevaert","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib57","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","article-title":"IL-5 synthesis is upregulated in human nasal polyp tissue","volume":"99","author":"Bachert","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fmed.2017.00093","article-title":"The biology of eosinophils and their role in asthma","volume":"4","author":"McBrien","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib59","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaci.2022.02.016","article-title":"Mechanisms and pathogenesis of chronic rhinosinusitis","volume":"149","author":"Kato","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4193\/Rhin08.109","article-title":"Relationship between epithelial damage or basement membrane thickness and eosinophilic infiltration in nasal polyps with chronic rhinosinusitis","volume":"47","author":"Saitoh","year":"2009","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2023.05.011_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2222.2000.00095.x","article-title":"Epithelial damage and response","volume":"30","author":"Holgate","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib62","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pupt.2013.06.003","article-title":"Cough, asthma, and cysteinyl-leukotrienes","volume":"26","author":"Niimi","year":"2013","journal-title":"Pulm Pharm Ther"},{"key":"10.1016\/j.jaip.2023.05.011_bib63","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/all.12010","article-title":"Role of imbalance of eicosanoid pathways and staphylococcal superantigens in chronic rhinosinusitis","volume":"67","author":"Pezato","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib64","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jaci.2021.08.015","article-title":"Eicosanoid dysregulation and type 2 inflammation in AERD","volume":"148","author":"Mullol","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib65","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jaci.2017.01.019","article-title":"Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation","volume":"139","author":"Gevaert","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/all.12111","article-title":"Extracellular DNA traps in allergic, infectious, and autoimmune diseases","volume":"68","author":"Simon","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib67","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12931-021-01759-z","article-title":"Raised sputum extracellular DNA confers lung function impairment and poor symptom control in an exacerbation-susceptible phenotype of neutrophilic asthma","volume":"22","author":"Abdo","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2023.05.011_bib68","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/bmm-2018-0280","article-title":"Charcot-Leyden crystal protein\/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma","volume":"13","author":"Nyenhuis","year":"2019","journal-title":"Biomark Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib69","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.coi.2021.03.013","article-title":"Charcot\u2013Leyden crystals and other protein crystals driving type 2 immunity and allergy","volume":"72","author":"Aegerter","year":"2021","journal-title":"Curr Op Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw4295","article-title":"Protein crystallization promotes type 2 immunity and is reversible by antibody treatment","volume":"364","author":"Persson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.jaip.2023.05.011_bib71","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/all.15627","article-title":"IL-5 receptor expression in lung fibroblasts: potential role in airway remodeling in asthma","volume":"78","author":"Bajbouj","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib72","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.158.8.3902","article-title":"Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia","volume":"158","author":"Simon","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib73","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.it.2013.08.004","article-title":"Innate immune cells in asthma","volume":"34","author":"Deckers","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib74","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jaci.2011.05.032","article-title":"IL-5 receptor alpha levels in patients with marked eosinophilia or mastocytosis","volume":"128","author":"Wilson","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221113","article-title":"Expression of IL-5 receptor alpha by murine and human lung neutrophils","volume":"14","author":"Gorski","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2023.05.011_bib76","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/all.13451","article-title":"Immunological and hematological effects of IL-5 (R\u03b1)-targeted therapy: an overview","volume":"73","author":"Hassani","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib77","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0091-6749(96)70195-1","article-title":"Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge","volume":"97","author":"Sur","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib78","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1084\/jem.172.5.1525","article-title":"Enhancement of human basophil histamine release by interleukin 5","volume":"172","author":"Hirai","year":"1990","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib79","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.175.4.973","article-title":"Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig) G1 and IgE","volume":"175","author":"Purkerson","year":"1992","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib80","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.4049\/jimmunol.172.10.6020","article-title":"The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production","volume":"172","author":"Moon","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib81","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/1521-4141(200006)30:6<1733::AID-IMMU1733>3.0.CO;2-E","article-title":"A\u00a0role for IL-5 in the induction of cytotoxic T lymphocytes in\u00a0vivo","volume":"30","author":"Apostolopoulos","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib82","doi-asserted-by":"crossref","first-page":"10509","DOI":"10.1073\/pnas.180318697","article-title":"IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production","volume":"97","author":"Ochi","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaip.2023.05.011_bib83","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4168\/aair.2021.13.3.363","article-title":"A\u00a0potential role of group 2 innate lymphoid cells in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"13","author":"Li","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2023.05.011_bib84","doi-asserted-by":"crossref","first-page":"208","DOI":"10.15586\/aei.v49i2.29","article-title":"Group 2 innate lymphoid cells (ILC2s): the spotlight in asthma pathogenesis and lung tissue injury","volume":"49","author":"Sadik","year":"2021","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.jaip.2023.05.011_bib85","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1084\/jem.172.6.1577","article-title":"Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists","volume":"172","author":"Bischoff","year":"1990","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/immadv\/ltab008","article-title":"Behind the scenes with basophils: an emerging therapeutic target","volume":"1","author":"Shah","year":"2021","journal-title":"Immunother Adv"},{"key":"10.1016\/j.jaip.2023.05.011_bib87","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/all.13197","article-title":"Airway basophils are increased and activated in eosinophilic asthma","volume":"72","author":"Suzuki","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib88","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/eji.1830180615","article-title":"Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen","volume":"18","author":"P\u00e8ne","year":"1988","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib89","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.4049\/jimmunol.1400732","article-title":"IL-5 triggers a cooperative cytokine network that promotes eosinophil precursor maturation","volume":"193","author":"Fulkerson","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib90","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/alr.22214","article-title":"Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement","volume":"8","author":"Lou","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib91","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/all.13496","article-title":"Precision medicine in united airways disease: a \u201ctreatable traits\u201d approach","volume":"73","author":"Yii","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib92","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/cea.13790","article-title":"Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate-to-severe asthma","volume":"51","author":"Chen","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib93","first-page":"PA1096","article-title":"Patients with allergic and eosinophilic asthma in the German severe asthma registry","volume":"46","author":"Holstege","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.011_bib94","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3390\/biomedicines9111684","article-title":"Characterization of T2-low and T2-high asthma phenotypes in real-life","volume":"9","author":"Ricciardolo","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaip.2023.05.011_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/21526567211003844","article-title":"Factors affecting the control of chronic rhinosinusitis with nasal polyps: a comparison in patients with or without NERD","volume":"12","author":"Lilja","year":"2021","journal-title":"Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib96","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/all.14287","article-title":"Cold-inducible RNA-binding protein contributes to tissue remodeling in chronic rhinosinusitis with nasal polyps","volume":"76","author":"Shi","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib97","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00405-020-06174-6","article-title":"Can the systemic immune inflammation index preoperatively predict nasal polyp subtypes?","volume":"277","author":"Sivrice","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2023.05.011_bib98","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/alr.22901","article-title":"Predictive value of clinical characteristics in eosinophilic chronic rhinosinusitis with nasal polyps: a cross-sectional study in the Chinese population","volume":"12","author":"Yu","year":"2022","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib99","article-title":"Comparison of blood and tissue eosinophil count and blood IgE in patients with chronic sinusitis and nasal polyps","volume":"2021","author":"Asghari","year":"2021","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.jaip.2023.05.011_bib100","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2147\/JAA.S335964","article-title":"Serum YKL-40 levels predict endotypes and associate with postoperative recurrence in patients with chronic rhinosinusitis with nasal polyps","volume":"14","author":"Wen","year":"2021","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib101","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/cea.13841","article-title":"Clinical evaluation of type 2 disease status in a real-world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts","volume":"51","author":"Azim","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib102","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib103","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jaci.2017.10.005","article-title":"Biomarkers for severe eosinophilic asthma","volume":"140","author":"Yancey","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib104","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00634-2017","article-title":"Severe eosinophilic asthma: a roadmap to consensus","volume":"49","author":"Buhl","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.011_bib105","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib106","article-title":"Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland","volume":"5","author":"M\u00e4kel\u00e4","year":"2018","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.jaip.2023.05.011_bib107","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12890-016-0263-8","article-title":"Burden of asthma with elevated blood eosinophil levels","volume":"16","author":"Casciano","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib108","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1945892420936196","article-title":"Predictors of disease control after endoscopic sinus surgery plus long-term local corticosteroids in CRSwNP","volume":"35","author":"De Corso","year":"2021","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib109","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/alr.22702","article-title":"Inflammatory features and predictors for postsurgical outcomes in patients with nasal polyps stratified by local and systemic eosinophilia","volume":"11","author":"Pan","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib110","article-title":"Eosinophilia, asthma, NERD and the use of oral corticosteroids predict uncontrolled chronic rhinosinusitis with nasal polyps after surgery","volume":"5","author":"Penttil\u00e4","year":"2021","journal-title":"Asian Pac J Allergy Immunol. Published online September"},{"key":"10.1016\/j.jaip.2023.05.011_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2152656720956596","article-title":"Assessing cut-off points of eosinophils, nasal polyp, and Lund-Mackay scores to predict surgery in nasal polyposis: a real-world study","volume":"11","author":"Virkkula","year":"2020","journal-title":"Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib112","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/1945892420987439","article-title":"Mucosal eosinophilia and neutrophilia are not associated with QOL or olfactory function in chronic rhinosinusitis","volume":"35","author":"Farrell","year":"2021","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib113","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/cea.13747","article-title":"Impaired small airway function in non-asthmatic chronic rhinosinusitis with nasal polyps","volume":"50","author":"Du","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib114","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaci.2022.02.029","article-title":"Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps","volume":"150","author":"Bai","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106080","article-title":"Efficacy of benralizumab in severe asthma in real life and focus on nasal polyposis","volume":"171","author":"Bagnasco","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib116","article-title":"Benralizumab in patients with severe eosinophilic asthma with and without chronic rhinosinusitis with nasal polyps: an ANANKE study post-hoc analysis","volume":"3","author":"D\u2019Amato","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-020-00332-z","article-title":"Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma","volume":"10","author":"Wang","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib118","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1165\/ajrcmb.15.5.8918371","article-title":"Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects","volume":"15","author":"Sehmi","year":"1996","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaip.2023.05.011_bib119","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.anai.2016.12.018","article-title":"Two inflammatory phenotypes of nasal polyps and comorbid asthma","volume":"118","author":"Wu","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.wjorl.2018.08.003","article-title":"Current understanding of allergic fungal rhinosinusitis","volume":"4","author":"Tyler","year":"2018","journal-title":"World J Otorhinolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2023.05.011_bib121","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/alr.21674","article-title":"Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes","volume":"6","author":"Promsopa","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib122","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.011_bib123","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0385-8146(03)00051-8","article-title":"The effectiveness of steroid treatment in nasal polyposis","volume":"30","author":"Tuncer","year":"2003","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jaip.2023.05.011_bib124","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/alr.22064","article-title":"Asthma onset pattern and patient outcomes in a chronic rhinosinusitis population","volume":"8","author":"John Staniorski","year":"2018","journal-title":"Int Forum Allergy Rhino"},{"key":"10.1016\/j.jaip.2023.05.011_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-019-0303-6","article-title":"Benefits and harm of systemic steroids for short-and long-term use in rhinitis and rhinosinusitis: an EAACI position paper","volume":"10","author":"Hox","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib126","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1398-9995.2005.00725.x","article-title":"Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments","volume":"60","author":"Alobid","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib127","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-154-5-201103010-00003","article-title":"Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial","volume":"154","author":"Vaidyanathan","year":"2011","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib128","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/alr.22431","article-title":"Predictors of efficacy for combination oral and topical corticosteroids to treat patients with chronic rhinosinusitis with nasal polyps","volume":"9","author":"Epperson","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib129","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/alr.21182","article-title":"A\u00a0systematic review and meta-analysis of asthma outcomes following endoscopic sinus surgery for chronic rhinosinusitis","volume":"3","author":"Vashishta","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2023.05.011_bib130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-020-00932-6","article-title":"Effect of functional endoscopic sinus surgery on outcomes in chronic rhinosinusitis","volume":"20","author":"Alanin","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2023.05.011_bib131","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/all.13048","article-title":"Asthma quality of life and control after sinus surgery in patients with chronic rhinosinusitis","volume":"72","author":"Schlosser","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib141","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib167","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib168","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib169","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib170","article-title":"Efficacy and safety of omalizumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials","volume":"11","author":"Wu","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2023.05.011_bib132","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaip.2019.07.016","article-title":"Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis","volume":"8","author":"Maspero","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.011_bib133","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/all.15067","article-title":"Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: results from two randomized placebo-controlled phase 3 trials","volume":"77","author":"Mullol","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106938","article-title":"Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline","volume":"202","author":"Bourdin","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/JAA.S258594","article-title":"Anti-IL5 therapies for severe eosinophilic asthma: literature review and practical insights","volume":"13","author":"Menzella","year":"2020","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib136","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40629-022-00220-x","article-title":"Indicating biologics for chronic rhinosinusitis with nasal polyps (CRSwNP) Recommendations by German allergy and ORL societies AeDA and DGHNO for dupilumab, omalizumab, and mepolizumab","volume":"31","author":"Klimek","year":"2022","journal-title":"Allergo J Int"},{"key":"10.1016\/j.jaip.2023.05.011_bib137","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaip.2018.08.021","article-title":"Effects of reslizumab on asthma outcomes in a subgroup of eosinophilic asthma patients with self-reported chronic rhinosinusitis with nasal polyps","volume":"7","author":"Weinstein","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.011_bib138","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/all.14902","article-title":"Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis","volume":"77","author":"Canonica","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-019-0952-1","article-title":"Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis","volume":"19","author":"Numata","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-021-01746-4","article-title":"Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions","volume":"22","author":"Gibson","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2023.05.011_bib142","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jaci.2021.10.040","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count","volume":"149","author":"Bachert","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib143","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12016-022-08938-w","article-title":"Real-life effectiveness of benralizumab, mepolizumab and omalizumab in severe allergic asthma associated with nasal polyps","volume":"64","author":"Tiotiu","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib144","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jaci.2020.02.002","article-title":"Severe eosinophilic asthma with nasal polyposis: a phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy","volume":"145","author":"Howarth","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17534666211009398","article-title":"Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study","volume":"15","author":"Detoraki","year":"2021","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.jaip.2023.05.011_bib146","first-page":"PA3727","article-title":"Mepolizumab in the treatment of severe asthma with nasal polyposis: real-life study","volume":"58","author":"da Costa Martins","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.011_bib147","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/jpm12081304","article-title":"Mepolizumab improves outcomes of chronic rhinosinusitis with nasal polyps in severe asthmatic patients: a multicentric real-life study","volume":"12","author":"Gallo","year":"2022","journal-title":"J\u00a0Personalized Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib148","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.imlet.2022.06.009","article-title":"Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a pilot real-life study","volume":"248","author":"Cavaliere","year":"2022","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaip.2023.05.011_bib149","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1016\/j.jaip.2021.08.004","article-title":"Benralizumab effectiveness in severe eosinophilic asthma with and without chronic rhinosinusitis with nasal polyps: a real-world multicenter study","volume":"9","author":"Nolasco","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.05.011_bib150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/1945892420978351","article-title":"Effect of benralizumab in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a case series","volume":"35","author":"Chitguppi","year":"2021","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2058738420950851","article-title":"Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma","volume":"34","author":"Lombardo","year":"2020","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jaip.2023.05.011_bib152","first-page":"A2672","article-title":"Efficacy of mepolizumab in patients with severe eosinophilic asthma and concomitant aspirin-exacerbated respiratory disease: meta-analysis of two phase III trials","volume":"207","author":"Laidlaw","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib153","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2213-2600(20)30414-8","article-title":"Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial","volume":"9","author":"Harrison","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib154","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib155","doi-asserted-by":"crossref","first-page":"AB26","DOI":"10.1016\/j.jaci.2019.12.808","article-title":"Mepolizumab reduces exacerbations and improves health-related quality of life in patients with severe asthma and nasal polyps, sinusitis, or allergic rhinitis","volume":"145","author":"Jain","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib156","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/all.14809","article-title":"Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib157","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib158","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.05.011_bib159","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1398-9995.2008.01885.x","article-title":"Differential expression of the interleukin 5 receptor \u03b1 isoforms in blood and tissue eosinophils of nasal polyp patients","volume":"64","author":"Gevaert","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.05.011_bib160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.anai.2022.04.004","article-title":"Evaluating enrolment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps","volume":"129","author":"Borish","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.05.011_bib161","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2023.05.011_bib162","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00703-2018","article-title":"Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature","volume":"52","author":"Volmer","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2023.05.011_bib163","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4193\/Rhino15.367","article-title":"The risk of osteoporosis in oral steroid treatment for nasal polyposis: a systematic review","volume":"55","author":"Winblad","year":"2017","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2023.05.011_bib164","first-page":"A4837","article-title":"The impact of comorbid nasal polyps on real-world mepolizumab effectiveness in patients with severe asthma: results from the REALITI-A study","volume":"205","author":"Liu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2023.05.011_bib165","first-page":"RCT2900","article-title":"Late breaking abstract\u2014phase 2 trial evaluating the effects of dexpramipexole on blood eosinophils, lung function, and airway\u00a0biomarkers in eosinophilic asthma","volume":"58","author":"Siddiqui","year":"2021","journal-title":"Eur Respir Soc"},{"key":"10.1016\/j.jaip.2023.05.011_bib166","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1002\/lary.27564","article-title":"Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size","volume":"129","author":"Laidlaw","year":"2019","journal-title":"Laryngoscope"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823005470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823005470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:38:58Z","timestamp":1761975538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823005470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":169,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213219823005470"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.05.011","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti\u2013IL-5 Biologic Therapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}